Literature DB >> 12747978

Clinicopathological and immunohistochemical analysis of twenty-five head and neck osteosarcomas.

Ademar Takahama Junior1, Fábio de Abreu Alves, Clóvis Antonio Lopes Pinto, André Lopes Carvalho, Luiz Paulo Kowalski, Márcio Ajudarte Lopes.   

Abstract

The aim of this study was to analyze the clinicopathological features and immunohistochemical expression of p53, MDM2, CDK4, PCNA and Ki67 proteins in 25 head and neck osteosarcomas registered in a single institution. The mean age of the patients was 29 years and the most common site was the mandible (60%). The predominant histological type was the chondroblastic (72%) and 52% of the cases were classified as intermediate-grade of malignancy. The immunohistochemical analysis displayed positivity in 52% of the cases for p53, 24% for MDM2, 84% for CDK4, 92% for PCNA and 88% for Ki-67. The majority of cases were treated with surgery alone or associated with chemotherapy. Five patients developed local recurrences, four had distant metastasis and six had persistent disease after initial treatment. The overall 5-year and 10-year survival rates were 59% and 49%, respectively, and the most important prognostic factors were prior history of radiation exposure and osteoblastic histological type.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12747978     DOI: 10.1016/s1368-8375(03)00017-4

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  26 in total

1.  The Utility of MDM2 and CDK4 Immunohistochemistry and MDM2 FISH in Craniofacial Osteosarcoma.

Authors:  Abberly Lott Limbach; Mark W Lingen; James McElherne; Heather Mashek; Carrie Fitzpatrick; Elizabeth Hyjek; Reza Mostofi; Nicole A Cipriani
Journal:  Head Neck Pathol       Date:  2020-02-05

2.  Chondroblastic Variant of Osteosarcoma of Mandible: Report of a Rare Case.

Authors:  Kusuma Venkatesh; Tushar Priyanka; Niveditha Shankaran Rukmini; Jagannath Bisanna
Journal:  J Clin Diagn Res       Date:  2016-08-01

Review 3.  Prognostic value of p53 alterations in human osteosarcoma: a meta analysis.

Authors:  Dong Yao; Guo-Hong Cai; Jing Chen; Rui Ling; Sheng-Xi Wu; Yong-Ping Li
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

Review 4.  Adolescent and Young Adult Oral Maxillofacial Tumors: A Single-Institution Case Series and Literature Review.

Authors:  Anil P George; Michael R Markiewicz; Steven Garzon; Daniel K Choi
Journal:  J Adolesc Young Adult Oncol       Date:  2019-12-20       Impact factor: 2.223

5.  Prognostic factors for teenage and adult patients with high-grade osteosarcoma: an analysis of 240 patients.

Authors:  Ayse Durnali; Necati Alkis; Sengul Cangur; Fisun Ardic Yukruk; Ali Inal; Saadet Tokluoglu; Mehmet Metin Seker; Oznur Bal; Tulay Akman; Mevlude Inanc; Abdurrahman Isikdogan; Ayse Demirci; Kaan Helvaci; Berna Oksuzoglu
Journal:  Med Oncol       Date:  2013-06-09       Impact factor: 3.064

6.  Primary Osteosarcoma of the Skull Base in a Pregnant Patient.

Authors:  Julia F Malalis; John M Lee; Walter M Jay
Journal:  Neuroophthalmology       Date:  2013-01-29

7.  Chondroblastic osteosarcoma of the left zygomatic bone: Rare case report and review of the literature.

Authors:  Shubhangi Khandekar; Alka Dive; Prashant Munde; Prajakta Zade Fande
Journal:  J Oral Maxillofac Pathol       Date:  2014-05

8.  Juvenile trabecular ossifying fibroma: Immunohistochemical expression of MDM2, CDK4 and p53 compared to conventional ossifying fibroma.

Authors:  Nikolaos G Nikitakis; Maria Georgaki; Stavroula Merkourea; Risa Chaisuparat; Gary Warburton; Marcio A Lopes; John C Papadimitriou; Robert A Ord
Journal:  J Clin Exp Dent       Date:  2022-01-01

9.  Hypoxia markers in human osteosarcoma: an exploratory study.

Authors:  Hiroo Mizobuchi; José Manuel García-Castellano; Shaji Philip; John H Healey; Richard Gorlick
Journal:  Clin Orthop Relat Res       Date:  2008-06-05       Impact factor: 4.176

10.  High-grade chondroblastic and fibroblastic osteosarcoma of the upper jaw.

Authors:  Tommaso Cutilli; Secondo Scarsella; Desiderio Di Fabio; Antonio Oliva; Pasqualino Cargini
Journal:  Ann Maxillofac Surg       Date:  2011-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.